Insulin Balanced Infusion System

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
HyperglycemiaDiabetes
Interventions
DEVICE

glucose and insulin infusions

combined algorithm directed glucose and insulin infusion with 5 minute blood glucose measurements to direct glucose control; regular insulin and glucose are infused intravenously as adjusted by the algorithm without manual intervention in the group of diabetic individuals under study to adjust the glucose level to a target range of 80-180 mg/dl

Trial Locations (1)

32803

3113 Lawton Road, Orlando

Sponsors
All Listed Sponsors
lead

Admetsys Corporation

INDUSTRY